Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Local aid agencies: still waiting for a bigger share of the funding cake
03/27/2017. Donors and UN agencies who agreed to provide at least one quarter of humanitarian aid funding “as directly as possible” to local NGOs are struggling to deliver on their pledge.
Malteser International : Over five million people face starvation in South Sudan
06/21/2017. President of Malteser International Europe, Douglas Saurma-Jeltsch, announced increased funding for the stricken populations of the region.
US foreign aid cuts: what could impact be?
04/28/2017. A leaked State Department budget document lays out proposals for a 30.8 percent cut in development aid and plans to sharply cut back.
